We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
 

Latest News

Adaptimmune Announces New Board Appointments as Clinical Programmes Get Underway
News   Sep 22, 2011

Company prepares to open trials in further cancer indications in 2012.

READ MORE

GE Healthcare to Invest $1 Billion in New Oncology Solutions
News   Sep 17, 2011

Expanding advanced cancer diagnostic and molecular imaging capabilities.

READ MORE

Cancer-Killing Cells are Caught on Film in More 3D Detail Than Ever Before
News   Sep 16, 2011

Scientists reveal in more detail than ever before how white blood cells kill diseased tissue using deadly granules, in research published in PLoS Biology.

READ MORE

PharmaGap Announces Successful Completion of Liposomal Development
News   Sep 13, 2011

Company has successfully completed the design, development, manufacture and testing of a liposome formulation of both basic and enhanced versions of GAP-107B8.

READ MORE

Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
News   Sep 12, 2011

Collaboration to investigate potential of AtuPLEX™ in the development of novel microRNA therapeutics targeting cancer.

READ MORE

NIH Study Finds Two Doses of HPV Vaccine may be as Protective as Full Course
News   Sep 12, 2011

The results of the study, based on data from a community-based clinical trial of Cervarix in Costa Rica.

READ MORE

Lead Compound for Pancreatic Cancer and Non Small Cell Lung Cancer Identfied
News   Sep 09, 2011

Arch Biopartners Inc announces that it has identified a lead compound, named GH501a, for further development as potential treatment for non small cell lung cancer and pancreatic cancer.

READ MORE

Vermillion Announces Issuance of Patent for Lung Cancer
News   Sep 08, 2011

The United States Patent and Trademark Office (USPTO) has issued patent number 8,014,952 entitled " Serum Biomarkers in Lung Cancer " to the Company.

READ MORE

uOttawa and OHRI Scientists Make Historic Breakthrough in Cancer Therapy Trial
News   Sep 06, 2011

The study shows that an intravenously-delivered viral therapy can consistently infect and spread within tumours without harming normal tissues in humans.

READ MORE

Oxford BioTherapeutics Licenses Lonza’s GS Gene Expression System™
News   Sep 05, 2011

Agreement covers the research, development and commercial use of the GS System™ by Oxford BioTherapeutics.

READ MORE

 
Advertisement